Results 191 to 200 of about 234,929 (313)
The use of the first trimester (AST × LDH × urea) / (platelet × hemoglobin) index in the prediction of preeclampsia. [PDF]
Çitirke A +4 more
europepmc +1 more source
Chromosome Anomalies in the First Trimester
openaire +3 more sources
First trimester Down\u92s syndrome screening The role of biochemistry [PDF]
Ranta-Ylikulju, Jenni
core
ABSTRACT Aim In this article, we present two cases of severe fetal hemolytic anemia based on a beta‐thalassaemia trait inherited from a single parent. Results These cases, presented at 20 and 28 weeks' gestation, necessitated intra‐uterine blood transfusions.
Eva van der Meij +11 more
wiley +1 more source
Comprehensive first-trimester targeted metabolomics for early prediction and understanding of GDM pathophysiology. [PDF]
Mojsak P +8 more
europepmc +1 more source
ABSTRACT Hemolytic disease of the fetus and newborn (HDFN) remains a significant concern in prenatal care primarily caused by maternal alloimmunization against fetal red blood cell antigens, most commonly the D antigen. Noninvasive fetal RHD genotyping, used as a screening tool, enables targeted antenatal prophylaxis and has been implemented in several
Emilie Thorup +4 more
wiley +1 more source
Herpes Simplex Virus 1 Encephalitis in First Trimester of Pregnancy: A Case Report. [PDF]
Furlan M, Lučovnik M, Kmet NG.
europepmc +1 more source
ABSTRACT Objective To investigate the additional clinical value of nuchal translucency (NT) measurement at the first‐trimester anomaly scan (FTAS) in a setting with first‐tier non‐invasive prenatal testing (NIPT). Method This nationwide prospective cohort study, part of the IMITAS study on FTAS implementation, included all pregnancies with increased NT
Eline E. R. Lust +15 more
wiley +1 more source
Early-onset gestational pemphigoid in the first trimester: a diagnostic pitfall. [PDF]
Di Lorito A +4 more
europepmc +1 more source
Attitudes Toward Prenatal Interventions in the Fanconi Anemia Community
ABSTRACT Objective In‐utero cell and gene therapies may offer prenatal treatment options for inherited diseases. Preclinical data suggests in‐utero (IU) hematopoietic stem cell transplantation (HSCT) could prevent Fanconi anemia (FA) related bone marrow failure without genotoxic conditioning or immune suppression.
Tony Lum +4 more
wiley +1 more source

